Miscellaneous Quiz / Adrenal Drugs

Random Miscellaneous Quiz

QUIZ: Can you name the Adrenal Drugs?

Quiz not verified by Sporcle

Forced Order
Challenge
Share
Tweet
Embed
Score 0/89 Timer 20:00
HintAnswer
MOA: Irreversible long-duration (14-48 hrs) blockade of α-receptor (α1 > α2). Also blocks H1-R, Ach-R, serotonin-R. Vasodilates & increases CO. Oral
Meprednisone class
Has both glucocorticoid and mineralocorticoid activity
SE: Oversecretion or overdosing may result in hypokalemia, metabolic alkalosis, HTN.
Contraindications: peptic ulcer, heart disease, HTN w/ heart failure, infectious diseases, psychosis, DM, osteoporosis, glaucoma
Mifepristone class
Aminoglutethimide class
MOA: Glucocorticoid receptor antagonist. Also blocks progesterone receptor (antiprogestin activity: a contraceptive-contragestive agent).
Route: Oral, injected, topical
Trilostane class
Anti-inflammatory: 15; Topical 7, Na Retaining: 0; Equivalent oral dose: 1.5 mg
P-kinetics:Shorter t1/2 (5-7 hrs) than phenoxybenzamine
Methylprednisone class
Use: Primary aldosteronism (Conn's syndrome). Used as a diuretic in CHF. Tx hirsutism
SE: Osteoporosis, severe myopathy, cataracts, glaucoma, peptic ulcers, hypokalemia, edema, HTN
SE: Serious SE unusual for short-term tx (< 2 weeks). Major SE(> 2 weeks of treatment): Iatrogenic Cushing's syndrome, adrenal suppression, acute pancreatitis (high dose tx; rare).
Use: Tx pregnant women w/ Cushing's. Dx of adrenal insufficiency (measure blood levels of 11-deoxycortisol & urinary 17-hydroxysteroid)
Drospirenone class
MOA: A more selective receptor antagonist
Route: Oral, injected
Spironolactone class
Phenoxybenzamine class
Special precautions: pts should be monitored for: hyperglycemia, glycosuria, edema or HTN, hypokalemia, peptic ulcers, osteoporosis.
Use: Cushing's syndrome, fungal infections
Use: Decrease steroid production in pts w/ Cushing's d/t adrenocortical CA (w/ metyrapone or ketoconazole)
Betamethasone class
Anti-inflammatory: 5; Na Retaining: 0; Equivalent oral dose: 4 mg
Use: Decrease estrogen production in breast CA pts (used in w/ dexamethasone or hydrocortisone).
Eplerenone class
SE: Abd pain, uterine cramping, bleeding. Causes glucocorticoid resistance
HintAnswer
Prenisolone class
Anti-inflammatory: 10; Topical 0, Na Retaining: 250; Equivalent oral dose: 2 mg
Anti-inflammatory: 5; Topical 4, Na Retaining: 0.3; Equivalent oral dose: 5 mg
Use: Dx purposes - dexamethasone suppression test - for Cushing's - measures response of the adrenal glands to ACTH
P-kinetics: High plasma PRO binding activity (albumin and glycoprotein but not CBG). T1/2 ~ 20 hours
Use: Prevention of chemo-induced emesis (e.g. dexamethasone prevents cisplatin-induced emesis)
SE: Postural hypotension, tachycardia, nasal stuffiness, inhibition of ejaculation, fatigue, sedation, nausea
Paramethasone class
Phentolamine class
SE: impaired wound healing, hyperglycemia, hyperlipidemia, anxiety, insomnia, depression, steroid psychosis, infections,
Metyrapone class
Fludrocortisone class
Use: Tx adrenal insufficiency associed w/ mineralocorticoid deficiency (i.e. Addison's dz)
Deoxycorticosterone class
Hydrocortisone (Cortisol) class
P-kinetics: Keep the dose low. Tx should not be decreased or stopped abruptly.
Use: For inoperable pts w/ adrenal CA who failed to respond to other txs. Abortificant (< 2mos). Emergency contraceptive (prevent ovulation).
Use: Pheochromocytomoa (esp intra-op) & ED
Aldosterone class
Anti-inflammatory: 4; Topical 0, Na Retaining: 0.3; Equivalent oral dose: 5 mg
Anti-inflammatory: 25-40; Topical 10, Na Retaining: 0; Equivalent oral dose: 0.6 mg
MOA: An analogue of spironolactone. Has anti-mineralocortioid & anti-androgenic activities.
Prednisone class
SE: Hyperkalemia, cardiac arrhythmia, gynecomastia, mentrual abnormalities, GI disturbances, skin rashes
SE: IV -Severe tachycardia, arrythmias, myocardial ischemia. Oral - tachycardia, nasal congestion, HA
SE: Hyperkalemia
Use: Tx of non-adrenal disorders -Suppress inflammatory & immune responses (e.g. arthritis, lupus, UC, asthma, SJS) - Use medium- to intermediate-acting glucocorticoids.
SE: Salt & fluid retention, hirsutism, dizziness, GI upset
Use: Tx of disturbed adrenal function - (1) Adrenocortical insufficiency [Chronic = Addison's dz or Acute]
MOA: Blocks progesterone receptors & androgen receptors -> Na loss & K retention
HintAnswer
Use: Pheochromocytoma (esp. pre-op)
MOA: Act on mineralocorticoid receptors. Activation of the aldosterone receptor -> increased expression of Na/K/ATPase. Increase reabsorption of Na & excretion of K.
Use: Tx hirsutism. May decrease PMDD. A progestin oral contraceptive (Yasmin)
Mitotane class
MOA: Inhibits cholesterol side chain cleavage (p450scc) & other p450 enzymes required for steroid synthesis
Anti-inflammatory: 1; Topical 1, Na Retaining: 1; Equivalent oral dose: 20 mg
Route: Injectable, pellets
Fluprenisolone class
Anti-inflammatory: 30; Topical 10; Na Retaining: 0; Equivalent oral dose: 0.75 mg
Ketoconazole class
Anti-inflammatory: 0.8; Topical 0, Na Retaining: 0.8; Equivalent oral dose: 25 mg
Use: Tx of disturbed adrenal function: (2) Adrenocortical hypo- or hyperfunction [congenital adrenal hyperplasia; glucocorticoid remediable aldosteronism (GRA)]
MOA: Blocks 11β-hydroxylase in steroid synthesis
Route: Oral
Anti-inflammatory: 0; Topical 0, Na Retaining: 20
Cortisone class
Anti-inflammatory: 10; Na Retaining: 0; Equivalent oral dose: 2 mg
Use: HTN
Use: Tx of tpx rejection- reduces antigen expression from grafted tissue; delays revascularization; interferes w/ sensitization of cytotoxic Tcells & generation of Ab-forming cells
SE: Lethary, dizziness, and skin rashs (at high doses)
Topical 5, Na Retaining: 0; Equivalent oral dose: 4 mg
DOC Acetate (DOCA)
Anti-inflammatory: 5; Topical 5; Na Retaining: 0; Equivalent oral dose: 4 mg
Triamcinolone class
SE: Hepatotoxicity. Interferes w/ the metabolism of sex steroid hormones, warfarin, phenytoin, etc.
MOA: Blocks synthesis of pregnenolone -> Decreased mineralocortioids, glucocorticoids & androgens/estrogens
Dexamethasone class
Use: Stimulation of fetal lung maturation - used in pregnant women to prevent RDS in preterm infants
MOA: A potent competitive α-antagonist (α1 = α2). Minor inhibitory effect on serotonin-R. Agonistic effects on MR & H1/H2-R. Decreased PVR, increased cardiac stim (reflex)

You're not logged in!

Compare scores with friends on all Sporcle quizzes.
Sign Up with Email
OR
Log In

You Might Also Like...

Show Comments

Extras

Top Quizzes Today


Score Distribution

Your Account Isn't Verified!

In order to create a playlist on Sporcle, you need to verify the email address you used during registration. Go to your Sporcle Settings to finish the process.